<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Einstein (Sao Paulo)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Einstein (Sao Paulo)</journal-id>
      <journal-id journal-id-type="publisher-id">eins</journal-id>
      <journal-title-group>
        <journal-title>Einstein</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1679-4508</issn>
      <issn pub-type="epub">2317-6385</issn>
      <publisher>
        <publisher-name>Instituto Israelita de Ensino e Pesquisa Albert Einstein</publisher-name>
        <publisher-loc>Sao Paulo</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24728253</article-id>
      <article-id pub-id-type="pmc">4898246</article-id>
      <article-id pub-id-type="publisher-id">S1679-45082014RC2729</article-id>
      <article-id pub-id-type="doi">10.1590/S1679-45082014RC2729</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Successful management of neonatal alloimmune thrombocytopenia in the second pregnancy: a case report</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Sucesso no manejo da trombocitopenia aloimune neonatal na segunda gesta&#xE7;&#xE3;o: relato de caso</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Conti</surname>
            <given-names>Fabiana Mendes</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hibner</surname>
            <given-names>Sergio</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Costa</surname>
            <given-names>Thiago Henrique</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dezan</surname>
            <given-names>Marcia Regina</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aravechia</surname>
            <given-names>Maria Giselda</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pereira</surname>
            <given-names>Ricardo Antonio D'Almeida</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kondo</surname>
            <given-names>Andrea Tiemi</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>D'Amico</surname>
            <given-names>&#xC9;lbio Ant&#xF4;nio</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mota</surname>
            <given-names>Mariza</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kutner</surname>
            <given-names>Jos&#xE9; Mauro</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <aff id="aff1"><label>1</label>Hospital Israelita Albert Einstein, S&#xE3;o Paulo, SP, Brazil</aff>
        <aff id="aff2"><label>2</label>Universidade de S&#xE3;o Paulo, S&#xE3;o Paulo, SP, Brazil</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1">Corresponding author: Fabiana Mendes Conti &#x2013; Department of Hemotherapy and Cell Therapy, Hospital Israelita Albert Einstein &#x2013; Avenida Albert Einstein, 627/701, 4th floor, building A &#x2013; Morumbi &#x2013; Zip code: 05652-900 &#x2013; S&#xE3;o Paulo, SP, Brazil &#x2013; Phone: <phone>(55 11) 2151-0444</phone> &#x2013; E-mail:<email>fabianaconti@einstein.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jan-Mar</season>
        <year>2014</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jan-Mar</season>
        <year>2014</year>
      </pub-date>
      <volume>12</volume>
      <issue>1</issue>
      <fpage>96</fpage>
      <lpage>99</lpage>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>12</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>03</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p> This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <title>ABSTRACT</title>
        <p>Neonatal alloimmune thrombocytopenia is a serious disease, in which the mother produces antibodies against fetal platelet antigens inherited from the father; it is still an underdiagnosed disease. This disease is considered the platelet counterpart of the RhD hemolytic disease of the fetus and newborn, yet in neonatal alloimmune thrombocytopenia the first child is affected with fetal and/or neonatal thrombocytopenia. There is a significant risk of intracranial hemorrhage and severe neurological impairment, with a tendency for earlier and more severe thrombocytopenia in subsequent pregnancies. This article reports a case of neonatal alloimmune thrombocytopenia in the second pregnancy affected and discusses diagnosis, management and the clinical importance of this disease.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <title>RESUMO</title>
        <p>A p&#xFA;rpura trombocitop&#xEA;nica neonatal aloimune &#xE9; uma doen&#xE7;a grave, na qual a m&#xE3;e produz anticorpos contra ant&#xED;genos plaquet&#xE1;rios fetais herdados do pai, e &#xE9; ainda subdiagnosticada na pr&#xE1;tica cl&#xED;nica. &#xC9; considerada o equivalente plaquet&#xE1;rio da doen&#xE7;a hemol&#xED;tica do rec&#xE9;m-nascido, com a diferen&#xE7;a que o primeiro filho &#xE9; afetado, apresentando trombocitopenia fetal e/ou neonatal. H&#xE1; risco significativo de hemorragia intracraniana e sequelas neurol&#xF3;gicas graves, com tend&#xEA;ncia a trombocitopenia mais grave e mais precoce nas gesta&#xE7;&#xF5;es subsequentes. Este artigo relata um caso de trombocitopenia aloimune neonatal na segunda gesta&#xE7;&#xE3;o afetada e discute diagn&#xF3;stico, manejo e import&#xE2;ncia cl&#xED;nica dessa doen&#xE7;a na pr&#xE1;tica cl&#xED;nica.</p>
      </trans-abstract>
      <kwd-group>
        <title>Keywords:</title>
        <kwd>Thrombocytopenia</kwd>
        <kwd>Blood platelets</kwd>
        <kwd>Thrombocytopenia, neonatal alloimmune</kwd>
        <kwd>Infant, newborn</kwd>
        <kwd>Case reports</kwd>
      </kwd-group>
      <counts>
        <fig-count count="4"/>
        <table-count count="2"/>
        <equation-count count="0"/>
        <ref-count count="15"/>
        <page-count count="4"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Neonatal alloimmune thrombocytopenia (NAIT) is a disease in which the mother produces antibodies against fetal platelet antigens inherited from the father and which the mother lacks.<sup>(<xref rid="B1" ref-type="bibr">1</xref>&#x2013;<xref rid="B3" ref-type="bibr">3</xref>)</sup> It is the platelet counterpart of the RhD hemolytic disease of the fetus and newborn. However, NAIT affects the first pregnancy and can cause intracranial hemorrhage (ICH), with a tendency for earlier and more severe thrombocytopenia in subsequent pregnancies.<sup>(<xref rid="B1" ref-type="bibr">1</xref>&#x2013;<xref rid="B5" ref-type="bibr">5</xref>)</sup>
</p>
      <p>We report the case of a 37-year-old woman with NAIT diagnosed in her first child and the strategy used to manage this second at-risk pregnancy.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 37-year-old Caucasian female from S&#xE3;o Paulo, Brazil, gave birth to a healthy male baby on February 2009 by vaginal delivery (40 weeks) weighing 3510g, Apgar 9 to 10 and no obstetric complications. In less than 24 hours of life, the newborn presented with petechiae and severe thrombocytopenia (14,000/mm<sup>3</sup>), despite normal hemoglobin and white blood cell (WBC) counts (<xref ref-type="table" rid="t1">Table 1</xref>) and absence of infection. The baby was transferred to the neonatal intensive care unit (NICU) for investigation.</p>
      <table-wrap id="t1" orientation="portrait" position="float">
        <label>Table 1</label>
        <caption>
          <title>Hematimetric parameters of the first newborn until discharge</title>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup width="10%" span="1">
            <col span="1"/>
            <col span="1"/>
            <col span="1"/>
            <col span="1"/>
            <col span="1"/>
            <col span="1"/>
            <col span="1"/>
            <col span="1"/>
            <col span="1"/>
            <col span="1"/>
          </colgroup>
          <thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
            <tr>
              <th align="left" rowspan="1" colspan="1"/>
              <th align="center" rowspan="1" colspan="1">2/26 D1</th>
              <th align="center" rowspan="1" colspan="1">2/27 D2</th>
              <th align="center" rowspan="1" colspan="1">2/28 D3</th>
              <th align="center" rowspan="1" colspan="1">3/2 D5</th>
              <th align="center" rowspan="1" colspan="1">3/3 D6</th>
              <th align="center" rowspan="1" colspan="1">3/4 D7</th>
              <th align="center" rowspan="1" colspan="1">3/5 D8</th>
              <th align="center" rowspan="1" colspan="1">3/6 D9</th>
              <th align="center" rowspan="1" colspan="1">3/8 D11</th>
            </tr>
          </thead>
          <tbody style="border-bottom: thin solid; border-color: #000000">
            <tr>
              <td align="left" rowspan="1" colspan="1">Erythrocytes (mm<sup>3</sup>)</td>
              <td align="center" rowspan="1" colspan="1">5.05</td>
              <td align="center" rowspan="1" colspan="1">4.89</td>
              <td align="center" rowspan="1" colspan="1">4.16</td>
              <td align="center" rowspan="1" colspan="1">3.57</td>
              <td align="center" rowspan="1" colspan="1">3.79</td>
              <td align="center" rowspan="1" colspan="1">3.32</td>
              <td align="center" rowspan="1" colspan="1">3.31</td>
              <td align="center" rowspan="1" colspan="1">3.28</td>
              <td align="center" rowspan="1" colspan="1">3.27</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Hemoglobin (g/dL)</td>
              <td align="center" rowspan="1" colspan="1">16.5</td>
              <td align="center" rowspan="1" colspan="1">15.6</td>
              <td align="center" rowspan="1" colspan="1">13.9</td>
              <td align="center" rowspan="1" colspan="1">11.3</td>
              <td align="center" rowspan="1" colspan="1">12.4</td>
              <td align="center" rowspan="1" colspan="1">10.6</td>
              <td align="center" rowspan="1" colspan="1">11.1</td>
              <td align="center" rowspan="1" colspan="1">10.5</td>
              <td align="center" rowspan="1" colspan="1">10.3</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Hematocrit (%)</td>
              <td align="center" rowspan="1" colspan="1">49.5</td>
              <td align="center" rowspan="1" colspan="1">48.2</td>
              <td align="center" rowspan="1" colspan="1">41.9</td>
              <td align="center" rowspan="1" colspan="1">35.8</td>
              <td align="center" rowspan="1" colspan="1">38.1</td>
              <td align="center" rowspan="1" colspan="1">32.6</td>
              <td align="center" rowspan="1" colspan="1">33.5</td>
              <td align="center" rowspan="1" colspan="1">31.2</td>
              <td align="center" rowspan="1" colspan="1">31.6</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">MCV (fL)</td>
              <td align="center" rowspan="1" colspan="1">97.6</td>
              <td align="center" rowspan="1" colspan="1">98.6</td>
              <td align="center" rowspan="1" colspan="1">100.7</td>
              <td align="center" rowspan="1" colspan="1">100.3</td>
              <td align="center" rowspan="1" colspan="1">100.5</td>
              <td align="center" rowspan="1" colspan="1">98.2</td>
              <td align="center" rowspan="1" colspan="1">99.7</td>
              <td align="center" rowspan="1" colspan="1">95.1</td>
              <td align="center" rowspan="1" colspan="1">96.6</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">MCHC (g/dL)</td>
              <td align="center" rowspan="1" colspan="1">33.4</td>
              <td align="center" rowspan="1" colspan="1">32.3</td>
              <td align="center" rowspan="1" colspan="1">33.2</td>
              <td align="center" rowspan="1" colspan="1">31.7</td>
              <td align="center" rowspan="1" colspan="1">32.5</td>
              <td align="center" rowspan="1" colspan="1">32.5</td>
              <td align="center" rowspan="1" colspan="1">33.6</td>
              <td align="center" rowspan="1" colspan="1">33.8</td>
              <td align="center" rowspan="1" colspan="1">32.7</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">RDW (%)</td>
              <td align="center" rowspan="1" colspan="1">15.1</td>
              <td align="center" rowspan="1" colspan="1">16.5</td>
              <td align="center" rowspan="1" colspan="1">15.7</td>
              <td align="center" rowspan="1" colspan="1">15.0</td>
              <td align="center" rowspan="1" colspan="1">15.8</td>
              <td align="center" rowspan="1" colspan="1">15.5</td>
              <td align="center" rowspan="1" colspan="1">14.9</td>
              <td align="center" rowspan="1" colspan="1">15.6</td>
              <td align="center" rowspan="1" colspan="1">16.6</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Leucocytes (mm<sup>3</sup>)</td>
              <td align="center" rowspan="1" colspan="1">37,200</td>
              <td align="center" rowspan="1" colspan="1">25,500</td>
              <td align="center" rowspan="1" colspan="1">19,700</td>
              <td align="center" rowspan="1" colspan="1">12,900</td>
              <td align="center" rowspan="1" colspan="1">18,300</td>
              <td align="center" rowspan="1" colspan="1">19,000</td>
              <td align="center" rowspan="1" colspan="1">17,800</td>
              <td align="center" rowspan="1" colspan="1">14,000</td>
              <td align="center" rowspan="1" colspan="1">12,000</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Platelets (mm<sup>3</sup>)</td>
              <td align="center" rowspan="1" colspan="1">14,000</td>
              <td align="center" rowspan="1" colspan="1">21,000</td>
              <td align="center" rowspan="1" colspan="1">20,000</td>
              <td align="center" rowspan="1" colspan="1">9,000</td>
              <td align="center" rowspan="1" colspan="1">16,000</td>
              <td align="center" rowspan="1" colspan="1">-</td>
              <td align="center" rowspan="1" colspan="1">27,000</td>
              <td align="center" rowspan="1" colspan="1">51,000</td>
              <td align="center" rowspan="1" colspan="1">81,000</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN1">
            <p>MCV: mean corpuscular volume; MCHC: mean corpuscular hemoglobin concentration; RDW: red cell distribution width.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>The platelet count reached its lowest level on day 4 (9,000/mm<sup>3</sup>), despite daily platelet transfusions and IV immunoglobulin 1g/kg. On day 8, platelets finally raised to 51,000/mm<sup>3</sup> and the baby was discharged with 81,000/mm<sup>3</sup> on day 9, without any bleeding complications.</p>
      <p>Human platelet antigen (HPA) genotyping showed that the mother was HPA-1b1b, the father HPA-1a1a and the child HPA-1a1b (<xref ref-type="fig" rid="f1">Figure 1</xref>). Maternal antibodies against HPA-1a were detected by monoclonal-specific antibody immobilization of platelet antigens (MAIPA), confirming the diagnosis of NAIT.</p>
      <fig id="f1" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <title>Summary of genotyping results from mother, father and first and second child</title>
        </caption>
        <graphic xlink:href="1679-4508-eins-12-01-0096-gf01"/>
      </fig>
      <p>In March 2012 this patient became pregnant again. The sibling was stratified to a standard risk of bleeding and intravenous immunoglobulin (IVIG) 1g/kg/week was started at week 17. Regular ultrasound scans were performed to monitor fetal ICH. At week 20, MAIPA was performed on the mother's serum and confirmed the anti-HPA-1a.</p>
      <p>Non-invasive follow-up with quantitative MAIPA was used to assess the risk of neonatal thrombocytopenia instead of cordocentesis. It was performed at weeks 25, 29 and 32, and the results were 29UI/mL, 21.69UI/mL and 32.51UI/mL, respectively (<xref ref-type="fig" rid="f2">Figure 2</xref>). Oral prednisone 40mg/day was started at week 32 and C-section was chosen to minimize the risk of bleeding at delivery. Moreover, HPA-1b1b donors were scheduled for plateletpheresis donation close to the estimated date of delivery.</p>
      <fig id="f2" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <title>Anti-HPA-1a titer curve in mother serum during second pregnancy by quantitative monoclonal-specific antibody immobilization of platelet antigens (MAIPA)</title>
        </caption>
        <graphic xlink:href="1679-4508-eins-12-01-0096-gf02"/>
      </fig>
      <p>The mother had moderate anemia during pregnancy (lowest level Hb=8.7g/dL at week 36). Hemolytic anemia due to IVIG was excluded by normal lactate dehydrogenase (LDH) levels (383mg/dL) and negative direct antiglobulin test. Since iron (87&#x3BC;g/dL) and ferritin (47.9&#x3B7;g/mL) levels were normal, anemia was considered dilutional and IVIG was not interrupted.</p>
      <p>Although delivery was scheduled for week 38, the woman went into labour and the baby was born at week 37, weighing 2750g and with Apgar 9 to 10, without petechiae or ecchymoses and a platelet count of 59,000/mm<sup>3</sup>. He remained in the neonatal ICU for close monitoring. Intracranial and abdominal ultrasound scans were normal. On day 2, he had 99,000/mm<sup>3</sup> platelets and was discharged on day 3, asymptomatic with platelet count of 150,000/mm<sup>3</sup>. Platelet transfusions were not necessary.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>NAIT affects 1:1000 live births, and in severe cases, evolves to ICH with severe neurological impairment in 10 to 22% of children, and 75% of bleeding occur antenatally.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> Despite being the most frequent cause of severe thrombocytopenia in fetuses and neonates, and the most frequent cause of ICH in the newborn,<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> it is underdiagnosed in routine clinical practice, with only 37% of severe cases detected in the absence of antenatal screening.<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> Antibodies against HPA-1a account for more than 80% of cases in Caucasians; anti-HPA-3a, &#x2212;4a and &#x2212;5a have also been reported.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup> Mothers have the rare HPA-1b1b genotype, whereas the fetus inherit a HPA-1a allele from the father.</p>
      <p>NAIT is suspected in a fetus with intracranial bleeding on ultrasound and neonates with bleeding or severe unexplained and/or isolated thrombocytopenia. The mother has normal platelet counts and no history of autoimmune disease or drug-induced thrombocytopenia.<sup>(<xref rid="B1" ref-type="bibr">1</xref>&#x2013;<xref rid="B3" ref-type="bibr">3</xref>)</sup>
</p>
      <p>Testing for fetal and neonatal alloimmune thrombocytopenia (FNAIT) should be performed in any neonate with unexplained thrombocytopenia &lt;50.000/mm<sup>3</sup>, regardless of the presumed cause.<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> Diagnosis is made by platelet genotyping showing HPA fetal-maternal incompatibility and detection of anti-HPA antibodies in the mother's serum.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>
</p>
      <p>There is a tendency for non-invasive monitoring during pregnancy, considering that 1.3% of fetal death cases per procedure and 5.5% cases per affected pregnancy were attributed to cordocentesis.<sup>(<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B5" ref-type="bibr">5</xref>&#x2013;<xref rid="B8" ref-type="bibr">8</xref>)</sup> The predictive value of the quantitative MAIPA for neonatal thrombocytopenia was reported by Bertrand et al.<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup>, in 2005, and results were confirmed by Killie et al., in 2008.<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup> The exact role of sequential quantitative anti-HPA measurements remains to be established, but antibody clearance along pregnancy seems to have a better prognosis.<sup>(<xref rid="B11" ref-type="bibr">11</xref>)</sup>
</p>
      <p>The maternal treatment of NAIT<sup>(<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B4" ref-type="bibr">4</xref>&#x2013;<xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B11" ref-type="bibr">11</xref>&#x2013;<xref rid="B14" ref-type="bibr">14</xref>)</sup> is based on the outcome of the first affected child and is classified into: (a) standard risk: first child with platelet &gt;20.000/mm<sup>3</sup> and no bleeding history; (b) high risk: platelet &lt;20.000/mm<sup>3</sup> or neonatal bleeding; (c) very high risk: fetal bleeding between 28 and 36 weeks; and (d) extremely high risk: fetal bleeding before 28 weeks. Weekly IVIG infusions are the treatment mainstay, varying in dose (1 to 2g/kg/week) and time to start (20 weeks or earlier). High-risk mothers receive higher IVIG doses and oral prednisone 0.5-1mg/kg, starting at 16 weeks for very high risk or 12 weeks for extremely high risk pregnancies.<sup>(<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B12" ref-type="bibr">12</xref>)</sup> C-section seems to be safer than vaginal delivery, especially when the fetal platelet count is unknown.<sup>(<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B14" ref-type="bibr">14</xref>)</sup>
</p>
      <p>HPA-matched platelet transfusions are indicated during the first 24 hours of life if platelets &lt;30.000/mm<sup>3</sup> or if there are signs of bleeding.<sup>(<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B15" ref-type="bibr">15</xref>)</sup> IVIG alone is not recommended, as it takes 24 to 48 hours to be effective with risk of central nervous system (CNS) bleeding<sup>(<xref rid="B5" ref-type="bibr">5</xref>)</sup> HPA-1b1b plateletpheresis donors should be contacted to donate close to the estimated date of delivery. Alternatively, the mother can donate platelets if feasible.<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup> IVIG 1g/kg for 2 days can be associated to platelet transfusions to the newborn in severe cases.<sup>(<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B15" ref-type="bibr">15</xref>)</sup>
</p>
    </sec>
    <sec sec-type="conclusions">
      <title>CONCLUSION</title>
      <p>Neonatal alloimmune thrombocytopenia is a serious underdiagnosed condition that affects the first child associated with significant morbidity. Close monitoring during pregnancy with ultrasound scans, treatment with immunoglobulin IV and/or corticosteroids and HPA-matched platelets at delivery can provide proper medical support to this condition and reduce the incidence of neurological sequelae in the newborn.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="financial-disclosure" id="fn1">
        <p>Financial sources: none.</p>
      </fn>
    </fn-group>
    <ack>
      <title>ACKNOWLEDGEMENTS</title>
      <p>We wish to thank Gerald Bertrand and Dr. C&#xE9;cile Kaplan for the technical support with quantitative monoclonal-specific antibody immobilization of platelet antigens and HPA DNA control samples.</p>
    </ack>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murphy</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Bussel</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Advances in the management of alloimmune thrombocytopenia</article-title>
          <source>Br J Haematol</source>
          <year>2007</year>
          <volume>136</volume>
          <issue>3</issue>
          <fpage>366</fpage>
          <lpage>378</lpage>
          <pub-id pub-id-type="pmid">17233844</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berkowitz</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Bussel</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>McFarland</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>Alloimmune thrombocytopenia: state of the art 2006</article-title>
          <source>Am J Obstet Gynecol</source>
          <year>2006</year>
          <volume>195</volume>
          <issue>4</issue>
          <fpage>907</fpage>
          <lpage>913</lpage>
          <pub-id pub-id-type="pmid">16875656</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Birchall</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kroll</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>European Fetomaternal Alloimmune Thrombocytopenia Study Group. European collaborative study of the antenatal management of foeto-maternal alloimmune thrombocytopenia</article-title>
          <source>Br J Hematol</source>
          <year>2003</year>
          <volume>122</volume>
          <issue>2</issue>
          <fpage>275</fpage>
          <lpage>288</lpage>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berkowitz</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Kolb</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>McFarland</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Wissert</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Primani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lesser</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia</article-title>
          <source>Obstet Gynecol</source>
          <year>2006</year>
          <volume>107</volume>
          <issue>1</issue>
          <fpage>91</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="pmid">16394045</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McQuilten</surname>
              <given-names>ZK</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Savoia</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Cole</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry</article-title>
          <source>Aust N Z J Obstet Gynaecol</source>
          <year>2011</year>
          <volume>51</volume>
          <issue>3</issue>
          <fpage>191</fpage>
          <lpage>199</lpage>
          <pub-id pub-id-type="pmid">21631435</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berkowitz</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Lesser</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>McFarland</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Wissert</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Primiani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hung</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia</article-title>
          <source>Obstet Gynaecol</source>
          <year>2007</year>
          <volume>110</volume>
          <issue>2 Pt 1</issue>
          <fpage>249</fpage>
          <lpage>255</lpage>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yinon</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Spira</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Solomon</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Weisz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Chayen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Schiff</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Antenatal noninvasive treatment of patients at risk for alloimmune trombocytopenia without a history of intracranial hemorrhage</article-title>
          <source>Am J Obstet Gynecol</source>
          <year>2006</year>
          <volume>195</volume>
          <issue>4</issue>
          <fpage>1153</fpage>
          <lpage>1157</lpage>
          <pub-id pub-id-type="pmid">17000248</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van den Akker</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Oepkes</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lopriore</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Brand</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kanhai</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <article-title>Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective</article-title>
          <source>BJOG</source>
          <year>2007</year>
          <volume>114</volume>
          <issue>4</issue>
          <fpage>469</fpage>
          <lpage>473</lpage>
          <pub-id pub-id-type="pmid">17309545</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bertrand</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Martageix</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jallu</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Vitry</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia</article-title>
          <source>J Thromb Haemost</source>
          <year>2006</year>
          <volume>4</volume>
          <issue>3</issue>
          <fpage>628</fpage>
          <lpage>637</lpage>
          <pub-id pub-id-type="pmid">16460445</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Killie</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Husebekk</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kjeldsen-Kragh</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Skogen</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn</article-title>
          <source>Haematologica</source>
          <year>2008</year>
          <volume>93</volume>
          <issue>6</issue>
          <fpage>870</fpage>
          <lpage>877</lpage>
          <pub-id pub-id-type="pmid">18443267</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bertrand</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Jallu</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Gouet</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kjaer</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Lambin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Husebekk</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Quantification of human platelet antigen-1a antibodies with the monoclonal antibody immobilization of platelet antigens procedure</article-title>
          <source>Transfusion</source>
          <year>2005</year>
          <volume>45</volume>
          <issue>8</issue>
          <fpage>1319</fpage>
          <lpage>1323</lpage>
          <pub-id pub-id-type="pmid">16078919</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bussel</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Berkowitz</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Hung</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kolb</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Wissert</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Primiani</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus</article-title>
          <source>Am J Obstet Gynecol</source>
          <year>2010</year>
          <volume>203</volume>
          <issue>2</issue>
          <fpage>135.e1</fpage>
          <lpage>135.e14</lpage>
          <pub-id pub-id-type="pmid">20494333</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vinograd</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Bussel</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Antenatal treatment of fetal alloimmune thrombocytopenia: a current perspective</article-title>
          <source>Haematologica</source>
          <year>2010</year>
          <volume>95</volume>
          <issue>11</issue>
          <fpage>1807</fpage>
          <lpage>1811</lpage>
          <pub-id pub-id-type="pmid">21037327</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <name>
              <surname>Paidas</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <comment>Prenatal management of neonatal alloimmune thrombocytopenia</comment>
          <source>UpToDate [Internet]</source>
          <year>2011</year>
          <date-in-citation content-type="access-date">[cited 2013 Dec 2]</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.uptodate.com">http://www.uptodate.com</ext-link></comment>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <name>
              <surname>Kaplan-Gouet</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <comment>Fetal and neonatal alloimmune thrombocytopenia</comment>
          <source>Orphanet [Internet]</source>
          <year>2003</year>
          <date-in-citation content-type="access-date">[cited 3/11/2013]</date-in-citation>
          <comment>Available from: http://<ext-link ext-link-type="uri" xlink:href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Expert=853&#x3B5;&#x2020;lng=EN">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Expert=853&#x3B5;&#x2020;lng=EN</ext-link></comment>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
